
	<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"	xmlns:cr_unixml="http://www.crossref.org/xschema/1.0" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
	<responseDate>2026-08-12T20:19:30+03:30</responseDate>
	<request metadataPrefix="cr_unixml" verb="ListRecords" set="10.1002">http://ijrm.ir/browse.php?mag_id=69&amp;slc_lang=en&amp;sid=1</request>
	<ListRecords>
		
			
				<record>
					<header>
						<identifier>69-626</identifier>
						<datestamp>2026-08-12</datestamp>
						<setSpec>10.1002</setSpec>
					</header>
					<metadata>
						<cr_unixml:crossref xmlns="http://www.crossref.org/xschema/1.0"
							xsi:schemaLocation="http://www.crossref.org/xschema/1.0 http://www.crossref.org/schema/unixref1.0.xsd">
							<journal>
								<journal_metadata language="en">
									<full_title>International Journal of Reproductive BioMedicine</full_title>
									<abbrev_title>IJRM</abbrev_title>
									<issn media_type="print">2476-4108</issn>
									<issn media_type="electronic">2476-3772</issn>
									<doi_data>
										<doi>10.29252/ijrm</doi>
										<resource></resource>
									</doi_data>
								</journal_metadata>
								<journal_issue>
									<publication_date media_type="print">
										<year>2015</year>
									</publication_date>
									<journal_volume>
										<volume>13</volume>
									</journal_volume>
									<issue>3</issue>
									<doi_data>
										<doi></doi>
										<resource></resource>
									</doi_data>
								</journal_issue>
								<journal_article publication_type="full_text">
									<titles>
										<title>Corrigenda</title>
									</titles>

				<contributors>
				
				<person_name contributor_role="author" sequence="1">
					<given_name>Fatemeh</given_name>
					<surname>Bazarganipour</surname>
					<email></email>
				</person_name>
				
				</contributors>
			
			<abstract>
			-
			</abstract>
				<keywords>
	</keywords>

							  <publication_date media_type="print">
								  <year>2015</year>
								  <month>3</month>
								  <day>01</day>
							  </publication_date>
							  <pages>
								  <first_page>0</first_page>
								  <last_page>0</last_page>
							  </pages>
								  <fullTextUrl>http://ijrm.ir/article-1-626-en.pdf</fullTextUrl>
							  <doi_data>
								  <doi></doi>
								  <resource></resource>
							  </doi_data>
							  <citation_list>
							  </citation_list>
						  </journal_article>
					  </journal>
				  </cr_unixml:crossref>
			  </metadata>
			</record>
				
			
				<record>
					<header>
						<identifier>69-633</identifier>
						<datestamp>2026-08-12</datestamp>
						<setSpec>10.1002</setSpec>
					</header>
					<metadata>
						<cr_unixml:crossref xmlns="http://www.crossref.org/xschema/1.0"
							xsi:schemaLocation="http://www.crossref.org/xschema/1.0 http://www.crossref.org/schema/unixref1.0.xsd">
							<journal>
								<journal_metadata language="en">
									<full_title>International Journal of Reproductive BioMedicine</full_title>
									<abbrev_title>IJRM</abbrev_title>
									<issn media_type="print">2476-4108</issn>
									<issn media_type="electronic">2476-3772</issn>
									<doi_data>
										<doi>10.29252/ijrm</doi>
										<resource></resource>
									</doi_data>
								</journal_metadata>
								<journal_issue>
									<publication_date media_type="print">
										<year>2015</year>
									</publication_date>
									<journal_volume>
										<volume>13</volume>
									</journal_volume>
									<issue>3</issue>
									<doi_data>
										<doi></doi>
										<resource></resource>
									</doi_data>
								</journal_issue>
								<journal_article publication_type="full_text">
									<titles>
										<title>Assessment on the adverse effects of Aminoglycosides and Flouroquinolone on sperm parameters and male reproductive tissue: A systematic review</title>
									</titles>

				<contributors>
				
				<person_name contributor_role="author" sequence="1">
					<given_name>Arash</given_name>
					<surname>Khaki</surname>
					<email>arashkhaki@yahoo.com</email>
				</person_name>
				
				</contributors>
			
			<abstract>
			Background: Antibiotic therapies used in treatment of many diseases have adverse effects on fertility. This review analyzes previous comparative studies that surveyed the effects of two common groups of antibiotics on male fertility.
Objective: To evaluate histo-pathological effects of fluoroquinolones and aminoglycosides on sperm parameters and male reproductive tissue.
Materials and Methods: Articles about the effects of aminoglycosides and fluoroquinolones on male infertility, sperm parameters, male reproductive tissue, and spermatogenesis in English and Persian languages published on Google Scholar and PubMed databases from January 2000 to December 2013 were assessed. Randomized controlled trials (RCTs) assessing the effects of aminoglycosides or fluoroquinolones on sperm parameters, artificial insemination, and male reproductive tract or RCTs comparing aminoglycosides vs. fluoroquinolones were eligible for inclusion. For ascertaining the reliability of study, data were extracted independently and in duplicate by two investigators.
Results: Sperm viability was decreased significantly with streptomycin, gentamicin, and neomycin (p&#60;0.001). Sperm motility was decreased significantly with gentamicin and neomycin (p&#60;0.05). Total sperm count was significantly decreased with ofloxacin, gentamicin, streptomycin, and neomycin (p&#60;0.022). There was significant decrease in post-thawing motility with low dose and high dose of ciprofloxacin. Testis weight was decreased with gentamicin and ofloxacin significantly (p&#60;0.011). There was significant decrease in seminal vesicle weight with gentamicin, neomycin, and ofloxacin (p&#60;0.022). Furthermore, changes in epididymis weight, percentage of total apoptotic cells, and diameter of seminiferous tubule were significant with all drugs including streptomycin, gentamicin, neomycin, and ofloxacin (p&#60;0.05).
Conclusion: Streptomycin has less negative effects on cell&#8217;s apoptosis and sperm parameters as compared to other drugs. Gentamicin has more detrimental effects so lesser dosage and duration is recommended. Fluoroquinolones showed negative effects on testis tissue and sperm parameters. Ciprofloxacin has less adverse effects than gentamicin in artificial insemination.
			</abstract>
				<keywords>
	<keyword>Aminoglycosides</keyword>
	<keyword>Fluoroquinolones</keyword>
	<keyword>Sperm</keyword>
	<keyword>Male reproductive tract</keyword>
	</keywords>

							  <publication_date media_type="print">
								  <year>2015</year>
								  <month>3</month>
								  <day>01</day>
							  </publication_date>
							  <pages>
								  <first_page>125</first_page>
								  <last_page>134</last_page>
							  </pages>
								  <fullTextUrl>http://ijrm.ir/article-1-633-en.pdf</fullTextUrl>
							  <doi_data>
								  <doi></doi>
								  <resource></resource>
							  </doi_data>
							  <citation_list>
							  </citation_list>
						  </journal_article>
					  </journal>
				  </cr_unixml:crossref>
			  </metadata>
			</record>
				
			
				<record>
					<header>
						<identifier>69-634</identifier>
						<datestamp>2026-08-12</datestamp>
						<setSpec>10.1002</setSpec>
					</header>
					<metadata>
						<cr_unixml:crossref xmlns="http://www.crossref.org/xschema/1.0"
							xsi:schemaLocation="http://www.crossref.org/xschema/1.0 http://www.crossref.org/schema/unixref1.0.xsd">
							<journal>
								<journal_metadata language="en">
									<full_title>International Journal of Reproductive BioMedicine</full_title>
									<abbrev_title>IJRM</abbrev_title>
									<issn media_type="print">2476-4108</issn>
									<issn media_type="electronic">2476-3772</issn>
									<doi_data>
										<doi>10.29252/ijrm</doi>
										<resource></resource>
									</doi_data>
								</journal_metadata>
								<journal_issue>
									<publication_date media_type="print">
										<year>2015</year>
									</publication_date>
									<journal_volume>
										<volume>13</volume>
									</journal_volume>
									<issue>3</issue>
									<doi_data>
										<doi></doi>
										<resource></resource>
									</doi_data>
								</journal_issue>
								<journal_article publication_type="full_text">
									<titles>
										<title>Types of reproductive disorders in underweight and overweight young females and correlations of respective hormonal changes with BMI</title>
									</titles>

				<contributors>
				
				<person_name contributor_role="author" sequence="1">
					<given_name>Nutsa</given_name>
					<surname>Aladashvili-Chikvaidze</surname>
					<email>nutsa.aladashvili@gmail.com</email>
				</person_name>
					
				<person_name contributor_role="author" sequence="2">
					<given_name>Jenara</given_name>
					<surname>Kristesashvili</surname>
					<email></email>
				</person_name>
					
				<person_name contributor_role="author" sequence="3">
					<given_name>Manana</given_name>
					<surname>Gegechkori</surname>
					<email></email>
				</person_name>
				
				</contributors>
			
			<abstract>
			Background: Higher risks of reproductive problems have been found in underweight and overweight women with rapid weight gain or loss but evidence is inconsistent especially in relation to the effect of age of body weight changes.
Objective: The aim of our study was to detect the peculiarities of menstrual function, prevalence of different types of reproductive disorders and correlations of respective hormonal changes with body mass index (BMI) in young female patients with thinness or obesity since childhood.
Materials and Methods: In this prospective cross-sectional study 48 underweight and 55 overweight/obese young women with different reproductive problems underwent complete clinical and hormonal analyses. All 103 patients had weight problems since childhood.
Results: Polycystic ovarian syndrome and metabolic syndrome was the most frequent in overweight and obese women, whilst non-classical congenital adrenal hyperplasia and ovarian dysfunction prevailed in underweight women (p˂0.001). No difference was determined according to the age of menarche (p=0.885) and types of menstrual disturbances (p=0.34) between the study groups. Hypogonadotropic hypogonadism was not found in young women who were lean since childhood. Follicle-stimulating hormone (FSH) (p=0.013) and sex hormone binging globulin (SHBG) (p˂0.001) levels were higher in women with low BMI, whilst free testosterone (FT) (p=0.019) and total testosterone (TT) (p=0.003) levels were higher in high BMI participants. BMI negatively correlated with FSH (p=0.009) and SHBG (p=0.001); and positively correlated with FT (p=0.001) and TT (p=0.002).
Conclusion: Peculiarities of menstrual function and hormonal changes in young women with thinness or obesity since childhood are related to the types of reproductive disorders and their childhood BMI.
			</abstract>
				<keywords>
	<keyword>Body mass index</keyword>
	<keyword>Body weight changes</keyword>
	<keyword>Childhood obesity</keyword>
	<keyword>Thinness</keyword>
	<keyword>Reproductive health</keyword>
	</keywords>

							  <publication_date media_type="print">
								  <year>2015</year>
								  <month>3</month>
								  <day>01</day>
							  </publication_date>
							  <pages>
								  <first_page>135</first_page>
								  <last_page>140</last_page>
							  </pages>
								  <fullTextUrl>http://ijrm.ir/article-1-634-en.pdf</fullTextUrl>
							  <doi_data>
								  <doi></doi>
								  <resource></resource>
							  </doi_data>
							  <citation_list>
							  </citation_list>
						  </journal_article>
					  </journal>
				  </cr_unixml:crossref>
			  </metadata>
			</record>
				
			
				<record>
					<header>
						<identifier>69-627</identifier>
						<datestamp>2026-08-12</datestamp>
						<setSpec>10.1002</setSpec>
					</header>
					<metadata>
						<cr_unixml:crossref xmlns="http://www.crossref.org/xschema/1.0"
							xsi:schemaLocation="http://www.crossref.org/xschema/1.0 http://www.crossref.org/schema/unixref1.0.xsd">
							<journal>
								<journal_metadata language="en">
									<full_title>International Journal of Reproductive BioMedicine</full_title>
									<abbrev_title>IJRM</abbrev_title>
									<issn media_type="print">2476-4108</issn>
									<issn media_type="electronic">2476-3772</issn>
									<doi_data>
										<doi>10.29252/ijrm</doi>
										<resource></resource>
									</doi_data>
								</journal_metadata>
								<journal_issue>
									<publication_date media_type="print">
										<year>2015</year>
									</publication_date>
									<journal_volume>
										<volume>13</volume>
									</journal_volume>
									<issue>3</issue>
									<doi_data>
										<doi></doi>
										<resource></resource>
									</doi_data>
								</journal_issue>
								<journal_article publication_type="full_text">
									<titles>
										<title>The viability of mouse spermatogonial germ cells on a novel scaffold, containing human serum albumin and calcium phosphate nanoparticles</title>
									</titles>

				<contributors>
				
				<person_name contributor_role="author" sequence="1">
					<given_name>Mona</given_name>
					<surname>Yadegar</surname>
					<email></email>
				</person_name>
					
				<person_name contributor_role="author" sequence="2">
					<given_name>Seyed Hossein</given_name>
					<surname>Hekmatimoghaddam</surname>
					<email></email>
				</person_name>
					
				<person_name contributor_role="author" sequence="3">
					<given_name>Saeide</given_name>
					<surname>Nezami Saridar</surname>
					<email></email>
				</person_name>
					
				<person_name contributor_role="author" sequence="4">
					<given_name>Ali</given_name>
					<surname>Jebali</surname>
					<email>alijebal2011@gmail.com</email>
				</person_name>
				
				</contributors>
			
			<abstract>
			Background: In spermatogenesis, spermatogonial cells differentiate to the haploid gametes. It has been shown that spermatogenesis can be done at in vitro condition. In vitro spermatogenesis may provide an open window to treat male infertility.
Objective: The aim of this study was to evaluate the effects of a novel scaffold containing human serum albumin (HSA)/tri calcium phosphate nanoparticles (TCP NPs) on the mouse spermatogonial cell line (SCL).
Materials and Methods: First, TCP NPs were synthesized by reaction of calcium nitrate and diammonium phosphate at pH 13. Then, serial concentrations of TCP NPs were separately added to 500 mg/mL HSA, and incubated in the 100oC water for 30 min. In the next step, each scaffold was cut (2&#215;2mm), placed into sterile well of microplate, and then incubated for 1, 2, and 3 days at 37oC with mouse SCL. After incubation, the cytotoxicity of the scaffolds was evaluated by different tests including 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide (MTT) assay, lactate dehydrogenase (LDH) assay, vital staining, and cell counting. On the other hand, the release of TCP NPs and HSA from the scaffolds was measured.
Results: Based on microscopic observation, the size of cavities for all scaffolds was near 200-500 &#956;m, and the size of TCP NPs was near 50-100 nm. All toxicity tests showed that the increase of TCP concentration in the scaffold did not affect mouse SCL. It means that the percentage of cell viability, LDH release, vital cells, and cell quantity was 85%, 105%, 90%, and 110%, respectively. But, the increase of incubation time led to increase of LDH release (up to 115%) and cell count (up to 115%). Also, little decrease of cell viability and vital cells was seen when incubation time was increased. Here, no release of TCP NPs and HSA was seen after increase of TCP concentration and incubation time.
Conclusion: It can be concluded that the increase of TCP concentration in HSA/ TCP NPs scaffold does not lead to cytotoxicity. On the other hand, the increase of incubation time leads to increase of mouse SCL cell death. In this study, it was found that TCP NPs and HSA could not release from the scaffolds. In future, both proliferation and differentiation of mouse SCL on HSA/TCP NPs scaffold must be checked over more wide incubation times.
			</abstract>
				<keywords>
	<keyword>Cytotoxic effect</keyword>
	<keyword>Scaffold</keyword>
	<keyword>Human serum albumin</keyword>
	<keyword>Calcium phosphate nanoparticles</keyword>
	<keyword>Spermatogonial cell line.</keyword>
	</keywords>

							  <publication_date media_type="print">
								  <year>2015</year>
								  <month>3</month>
								  <day>01</day>
							  </publication_date>
							  <pages>
								  <first_page>141</first_page>
								  <last_page>148</last_page>
							  </pages>
								  <fullTextUrl>http://ijrm.ir/article-1-627-en.pdf</fullTextUrl>
							  <doi_data>
								  <doi></doi>
								  <resource></resource>
							  </doi_data>
							  <citation_list>
							  </citation_list>
						  </journal_article>
					  </journal>
				  </cr_unixml:crossref>
			  </metadata>
			</record>
				
			
				<record>
					<header>
						<identifier>69-628</identifier>
						<datestamp>2026-08-12</datestamp>
						<setSpec>10.1002</setSpec>
					</header>
					<metadata>
						<cr_unixml:crossref xmlns="http://www.crossref.org/xschema/1.0"
							xsi:schemaLocation="http://www.crossref.org/xschema/1.0 http://www.crossref.org/schema/unixref1.0.xsd">
							<journal>
								<journal_metadata language="en">
									<full_title>International Journal of Reproductive BioMedicine</full_title>
									<abbrev_title>IJRM</abbrev_title>
									<issn media_type="print">2476-4108</issn>
									<issn media_type="electronic">2476-3772</issn>
									<doi_data>
										<doi>10.29252/ijrm</doi>
										<resource></resource>
									</doi_data>
								</journal_metadata>
								<journal_issue>
									<publication_date media_type="print">
										<year>2015</year>
									</publication_date>
									<journal_volume>
										<volume>13</volume>
									</journal_volume>
									<issue>3</issue>
									<doi_data>
										<doi></doi>
										<resource></resource>
									</doi_data>
								</journal_issue>
								<journal_article publication_type="full_text">
									<titles>
										<title>Comparison of anti-mullerian hormone level in non-endometriotic benign ovarian cyst before and after laparoscopic cystectomy</title>
									</titles>

				<contributors>
				
				<person_name contributor_role="author" sequence="1">
					<given_name>Sedigheh</given_name>
					<surname>Amooee</surname>
					<email></email>
				</person_name>
					
				<person_name contributor_role="author" sequence="2">
					<given_name>Mahboubeh</given_name>
					<surname>Gharib</surname>
					<email></email>
				</person_name>
					
				<person_name contributor_role="author" sequence="3">
					<given_name>Parsa</given_name>
					<surname>Ravanfar</surname>
					<email>ravanfarpa@yahoo.com</email>
				</person_name>
				
				</contributors>
			
			<abstract>
			Background: Benign ovarian cysts are common among both pre- and postmenstrual women. Surgical intervention for excision of an ovarian cyst is mandated when symptomatic, or chance for malignancy is high. The damaging effect of surgical ovarian cystectomy on ovarian reserve is debated in recent studies.
Objective: In the present study we investigated serum level of anti-mullerian hormone (AMH) as an indicator of ovarian reserve before and after surgical cystectomy.
Materials and Methods: 60 patients with dermoid cyst, serous cystadenoma, and mucinous cystadenoma were recruited. Measurement of serum AMH was performed prior to surgery, and at one and 3 months after laparoscopic cystectomy. Serum AMH levels were compared before and after the surgery and between various types of ovarian cyst.
Results: Serum AMH level declined significantly after the surgery which recovered to 65% of its baseline value three months later.
Conclusion: Decreased serum AMH can be contributed to decreased ovarian reserve after laparoscopic ovarian cystectomy. This can result from thermo-coagulation used for hemostasis during the operation.
			</abstract>
				<keywords>
	<keyword>Dermoid cyst</keyword>
	<keyword>Ovarian cyst</keyword>
	<keyword>Anti-mullerian hormone</keyword>
	<keyword>Cystadenoma</keyword>
	<keyword>Mucinous</keyword>
	<keyword>Serous.</keyword>
	</keywords>

							  <publication_date media_type="print">
								  <year>2015</year>
								  <month>3</month>
								  <day>01</day>
							  </publication_date>
							  <pages>
								  <first_page>149</first_page>
								  <last_page>154</last_page>
							  </pages>
								  <fullTextUrl>http://ijrm.ir/article-1-628-en.pdf</fullTextUrl>
							  <doi_data>
								  <doi></doi>
								  <resource></resource>
							  </doi_data>
							  <citation_list>
							  </citation_list>
						  </journal_article>
					  </journal>
				  </cr_unixml:crossref>
			  </metadata>
			</record>
				
			
				<record>
					<header>
						<identifier>69-629</identifier>
						<datestamp>2026-08-12</datestamp>
						<setSpec>10.1002</setSpec>
					</header>
					<metadata>
						<cr_unixml:crossref xmlns="http://www.crossref.org/xschema/1.0"
							xsi:schemaLocation="http://www.crossref.org/xschema/1.0 http://www.crossref.org/schema/unixref1.0.xsd">
							<journal>
								<journal_metadata language="en">
									<full_title>International Journal of Reproductive BioMedicine</full_title>
									<abbrev_title>IJRM</abbrev_title>
									<issn media_type="print">2476-4108</issn>
									<issn media_type="electronic">2476-3772</issn>
									<doi_data>
										<doi>10.29252/ijrm</doi>
										<resource></resource>
									</doi_data>
								</journal_metadata>
								<journal_issue>
									<publication_date media_type="print">
										<year>2015</year>
									</publication_date>
									<journal_volume>
										<volume>13</volume>
									</journal_volume>
									<issue>3</issue>
									<doi_data>
										<doi></doi>
										<resource></resource>
									</doi_data>
								</journal_issue>
								<journal_article publication_type="full_text">
									<titles>
										<title>Association between endometriosis and hyperprolactinemia in infertile women</title>
									</titles>

				<contributors>
				
				<person_name contributor_role="author" sequence="1">
					<given_name>Seddigheh</given_name>
					<surname>Esmaeilzadeh</surname>
					<email></email>
				</person_name>
					
				<person_name contributor_role="author" sequence="2">
					<given_name>Parvaneh</given_name>
					<surname>Mirabi</surname>
					<email>parvaneh_mirabi@yahoo.com</email>
				</person_name>
					
				<person_name contributor_role="author" sequence="3">
					<given_name>Zahra</given_name>
					<surname>Basirat</surname>
					<email></email>
				</person_name>
					
				<person_name contributor_role="author" sequence="4">
					<given_name>Mahtab</given_name>
					<surname>Zeinalzadeh</surname>
					<email></email>
				</person_name>
					
				<person_name contributor_role="author" sequence="5">
					<given_name>Soraya</given_name>
					<surname>Khafri</surname>
					<email></email>
				</person_name>
				
				</contributors>
			
			<abstract>
			Background: The association of endometriosis with hyperprolactinemia is controversial.
Objective: The present study aimed to determine the frequency of endometriosis and association of prolactin with endometriosis in infertile women.
Materials and Methods: 256 infertile women who underwent diagnostic laparoscopy for the evaluation of infertility, referred to Fatemezahra Infertility and Reproductive Health Research Center were included in a cross-sectional study. The presence of endometriosis was evaluated. To investigate the association of endometriosis with hyperprolactinemia, the patients whose infertility was not caused by endometriosis were included as control group. Serum prolactin (PRL) level was measured in both groups. The comparison of basal serum PRL levels between the two groups was performed, using independent t-test. One way ANOVA was used to determine PRL association with endometriosis stages.
Results: The frequency of endometriosis was found to be 29%. PRL levels were significantly higher in endometriosis group compared to control group (23.02&#177;1.25 vs. 17.22&#177;1.22 respectively, p=0.004). Statistically significant associations were found between staging of endometriosis and prolactin levels (p=0.01).
Conclusion: Hyperprolactinemia may be associated with endometriosis and its progression.
			</abstract>
				<keywords>
	<keyword>Endometriosis</keyword>
	<keyword>Infertility</keyword>
	<keyword>Hyperprolactinemia</keyword>
	<keyword>Laparoscopy</keyword>
	</keywords>

							  <publication_date media_type="print">
								  <year>2015</year>
								  <month>3</month>
								  <day>01</day>
							  </publication_date>
							  <pages>
								  <first_page>155</first_page>
								  <last_page>160</last_page>
							  </pages>
								  <fullTextUrl>http://ijrm.ir/article-1-629-en.pdf</fullTextUrl>
							  <doi_data>
								  <doi></doi>
								  <resource></resource>
							  </doi_data>
							  <citation_list>
							  </citation_list>
						  </journal_article>
					  </journal>
				  </cr_unixml:crossref>
			  </metadata>
			</record>
				
			
				<record>
					<header>
						<identifier>69-630</identifier>
						<datestamp>2026-08-12</datestamp>
						<setSpec>10.1002</setSpec>
					</header>
					<metadata>
						<cr_unixml:crossref xmlns="http://www.crossref.org/xschema/1.0"
							xsi:schemaLocation="http://www.crossref.org/xschema/1.0 http://www.crossref.org/schema/unixref1.0.xsd">
							<journal>
								<journal_metadata language="en">
									<full_title>International Journal of Reproductive BioMedicine</full_title>
									<abbrev_title>IJRM</abbrev_title>
									<issn media_type="print">2476-4108</issn>
									<issn media_type="electronic">2476-3772</issn>
									<doi_data>
										<doi>10.29252/ijrm</doi>
										<resource></resource>
									</doi_data>
								</journal_metadata>
								<journal_issue>
									<publication_date media_type="print">
										<year>2015</year>
									</publication_date>
									<journal_volume>
										<volume>13</volume>
									</journal_volume>
									<issue>3</issue>
									<doi_data>
										<doi></doi>
										<resource></resource>
									</doi_data>
								</journal_issue>
								<journal_article publication_type="full_text">
									<titles>
										<title>Intrauterine synechiae after myomectomy; laparotomy versus laparoscopy: Non-randomized interventional trial</title>
									</titles>

				<contributors>
				
				<person_name contributor_role="author" sequence="1">
					<given_name>Zahra</given_name>
					<surname>Asgari</surname>
					<email></email>
				</person_name>
					
				<person_name contributor_role="author" sequence="2">
					<given_name>Leili</given_name>
					<surname>Hafizi</surname>
					<email>hafizil@mums.ac.ir</email>
				</person_name>
					
				<person_name contributor_role="author" sequence="3">
					<given_name>Rayhaneh</given_name>
					<surname>Hosseini</surname>
					<email></email>
				</person_name>
					
				<person_name contributor_role="author" sequence="4">
					<given_name>Atiyeh</given_name>
					<surname>Javaheri</surname>
					<email></email>
				</person_name>
					
				<person_name contributor_role="author" sequence="5">
					<given_name>Hathis</given_name>
					<surname>Rastad</surname>
					<email></email>
				</person_name>
				
				</contributors>
			
			<abstract>
			Background: Leiomyomata is the most frequent gynecological neoplasm. One of the major complications of myomectomy is intrauterine adhesion (synechiae).
Objective: To evaluate and compare the rate and severity of synechiae formation after myomectomy by laparotomy and laparoscopy.
Materials and Methods: In this non-randomized interventional trial, hysteroscopy was performed in all married fertile women who had undergone myomectomy (type 3-6 interamural and subserosal fibroids) via laparotomy and laparoscopy in Tehran&#8217;s Arash Hospital from 2010 to 2013. Three months after the operation, the occurrence rate and severity of intrauterine synechiae, and its relationship with type, number and location of myomas were investigated and compared in both groups.
Results: Forty patients (19 laparoscopy and 21 laparotomy cases) were studied. Both groups were similar regarding the size, type (subserosal or intramural), number and location of myoma. The occurrence rate of synechiae in the laparoscopy and laparotomy group was 21% and 19%, respectively; showing no significant difference (p=0.99). Among all patients, no significant relationship was found between the endometrial opening (p=0.92), location (p=0.14) and type of myoma (p=0.08) with the occurrence rate of synechiae. However, a significant relationship was observed between myoma&#8217;s size (p=0.01) and the location of the largest myoma with the occurrence of synechiae (p=0.02).
Conclusion: With favorable suturing methods, the outcome of intrauterine synechiae formation after myomectomy, either performed by laparotomy or laparoscopy, is similar. In all cases of myomectomy in reproductive-aged women, postoperative hysteroscopy is highly recommended to better screen intrauterine synechiae.
			</abstract>
				<keywords>
	<keyword>Intrauterine synechiae</keyword>
	<keyword>Uterine myomectomy</keyword>
	<keyword>Laparotomy</keyword>
	<keyword>Laparoscopy</keyword>
	<keyword>Hysteroscopy</keyword>
	</keywords>

							  <publication_date media_type="print">
								  <year>2015</year>
								  <month>3</month>
								  <day>01</day>
							  </publication_date>
							  <pages>
								  <first_page>161</first_page>
								  <last_page>168</last_page>
							  </pages>
								  <fullTextUrl>http://ijrm.ir/article-1-630-en.pdf</fullTextUrl>
							  <doi_data>
								  <doi></doi>
								  <resource></resource>
							  </doi_data>
							  <citation_list>
							  </citation_list>
						  </journal_article>
					  </journal>
				  </cr_unixml:crossref>
			  </metadata>
			</record>
				
			
				<record>
					<header>
						<identifier>69-631</identifier>
						<datestamp>2026-08-12</datestamp>
						<setSpec>10.1002</setSpec>
					</header>
					<metadata>
						<cr_unixml:crossref xmlns="http://www.crossref.org/xschema/1.0"
							xsi:schemaLocation="http://www.crossref.org/xschema/1.0 http://www.crossref.org/schema/unixref1.0.xsd">
							<journal>
								<journal_metadata language="en">
									<full_title>International Journal of Reproductive BioMedicine</full_title>
									<abbrev_title>IJRM</abbrev_title>
									<issn media_type="print">2476-4108</issn>
									<issn media_type="electronic">2476-3772</issn>
									<doi_data>
										<doi>10.29252/ijrm</doi>
										<resource></resource>
									</doi_data>
								</journal_metadata>
								<journal_issue>
									<publication_date media_type="print">
										<year>2015</year>
									</publication_date>
									<journal_volume>
										<volume>13</volume>
									</journal_volume>
									<issue>3</issue>
									<doi_data>
										<doi></doi>
										<resource></resource>
									</doi_data>
								</journal_issue>
								<journal_article publication_type="full_text">
									<titles>
										<title>Association of assisted reproductive technology with adverse pregnancy outcomes</title>
									</titles>

				<contributors>
				
				<person_name contributor_role="author" sequence="1">
					<given_name>Zhang</given_name>
					<surname>Jie</surname>
					<email></email>
				</person_name>
					
				<person_name contributor_role="author" sequence="2">
					<given_name>Ding</given_name>
					<surname>Yiling</surname>
					<email>dingyilingcsu@sina.cn</email>
				</person_name>
					
				<person_name contributor_role="author" sequence="3">
					<given_name>Yu</given_name>
					<surname>Ling</surname>
					<email></email>
				</person_name>
				
				</contributors>
			
			<abstract>
			Background: More and more infertile patients have accepted the assisted reproductive technique (ART) therapy. Concerns have been raised over an increased risk of adverse maternal outcomes in ART populations as compared with natural conception (NC).
Objective: The aim was to improve the ART in clinicial work and to reduce the incidence of pregnancy complications in ART group according to analyzing the reasons of high incidence of pregnancy complications in ART group, comparing the incidence of pregnancy complications in different controlled ovarian hyperstimulation (COH) programs and evaluating the effects of ART which attribute to adverse pregnancy outcomes.
Materials and Methods: In this prospective population-based cohort study,3216 pregnant women with gestational age &#8804;12 weeks, regular antenatal examination,and ultrasound identification of intrauterine pregnancy were enrolled from January 2010 to June 2013. According to having ART history, the participantswere divided into two groups: ART group (contains fresh embryo transfer group or frozen-thawed embryo transfer group) and NC group. We compared the incidence of pregnancy complications between different groups and evaluated the factors which could affect the occurrence of these complications.
Results: When compared to NC group, significantly increased rates of gestational diabetes mellitus (GDM) (p&#60;0.01), preeclampsia (PE) (p&#60;0.01) and intrahepatic cholestasis of pregnancy (ICP) (p˂0.01) were observed in ART group. There was no significant difference in the incidence of birth defect between the two groups (p=0.07). Multiple pregnancies and Gonadotropin (Gn) were risk factors in GDM, PE, and ICP. The exogenous progesterone treatment had no effect on GDM, PE or ICP.
Conclusion: ART increases the risk of adverse maternal complications such as GDM, PE and ICP. The dosages of Gn should be reduced to an extent and the number of embryo implantation should be controlled. Exogenous progesterone treatment is safe.
			</abstract>
				<keywords>
	<keyword>Infertility</keyword>
	<keyword>Assisted reproductive technique</keyword>
	<keyword>Pregnancy complications</keyword>
	</keywords>

							  <publication_date media_type="print">
								  <year>2015</year>
								  <month>3</month>
								  <day>01</day>
							  </publication_date>
							  <pages>
								  <first_page>169</first_page>
								  <last_page>180</last_page>
							  </pages>
								  <fullTextUrl>http://ijrm.ir/article-1-631-en.pdf</fullTextUrl>
							  <doi_data>
								  <doi></doi>
								  <resource></resource>
							  </doi_data>
							  <citation_list>
							  </citation_list>
						  </journal_article>
					  </journal>
				  </cr_unixml:crossref>
			  </metadata>
			</record>
				
			
				<record>
					<header>
						<identifier>69-632</identifier>
						<datestamp>2026-08-12</datestamp>
						<setSpec>10.1002</setSpec>
					</header>
					<metadata>
						<cr_unixml:crossref xmlns="http://www.crossref.org/xschema/1.0"
							xsi:schemaLocation="http://www.crossref.org/xschema/1.0 http://www.crossref.org/schema/unixref1.0.xsd">
							<journal>
								<journal_metadata language="en">
									<full_title>International Journal of Reproductive BioMedicine</full_title>
									<abbrev_title>IJRM</abbrev_title>
									<issn media_type="print">2476-4108</issn>
									<issn media_type="electronic">2476-3772</issn>
									<doi_data>
										<doi>10.29252/ijrm</doi>
										<resource></resource>
									</doi_data>
								</journal_metadata>
								<journal_issue>
									<publication_date media_type="print">
										<year>2015</year>
									</publication_date>
									<journal_volume>
										<volume>13</volume>
									</journal_volume>
									<issue>3</issue>
									<doi_data>
										<doi></doi>
										<resource></resource>
									</doi_data>
								</journal_issue>
								<journal_article publication_type="full_text">
									<titles>
										<title>Neonatal diagnosis of 49, XXXXY syndrome</title>
									</titles>

				<contributors>
				
				<person_name contributor_role="author" sequence="1">
					<given_name>Katayoon</given_name>
					<surname>Etemadi</surname>
					<email>Katayoon_Etemadi@yahoo.com</email>
				</person_name>
					
				<person_name contributor_role="author" sequence="2">
					<given_name>Behnaz</given_name>
					<surname>Basir</surname>
					<email></email>
				</person_name>
					
				<person_name contributor_role="author" sequence="3">
					<given_name>Safieh</given_name>
					<surname>Ghahremani</surname>
					<email></email>
				</person_name>
				
				</contributors>
			
			<abstract>
			Background: 49, XXXXY syndrome is a rare sex chromosomal disorder, occurring in 1 per 85,000-100,000 male births. The classical phenotype is ambiguous genitalia, facial dysmorphism, mental retardation and a combination of cardiac, skeletal and other malformations.
Case: A two month-old boy with intrauterine growth restriction (IUGR) and low birth weight, facial dysmorphism, clinodactyly in feet, microphallus, and right undescendent testis were seen by neonatologist. Chromosomal studies via techniques of GTG-banding showed the constitution to be 49,XXXXY in all cells. He was visited by the pediatric cardiologist for congenital heart disease. No obvious malformation and congenital heart disease were seen.
Conclusion: In the case, the main presentation of IUGR and low birth weight, clinodactyly with facial dysmorphism and genital abnormalities led to a suspicion of a sex chromosome aneuploidy which was subsequently confirmed by chromosomal analysis.
			</abstract>
				<keywords>
	<keyword>49</keyword>
	<keyword>XXXXY syndrome</keyword>
	<keyword>Klinefelter syndrome</keyword>
	<keyword>Intrauterine growth restriction.</keyword>
	</keywords>

							  <publication_date media_type="print">
								  <year>2015</year>
								  <month>3</month>
								  <day>01</day>
							  </publication_date>
							  <pages>
								  <first_page>181</first_page>
								  <last_page>184</last_page>
							  </pages>
								  <fullTextUrl>http://ijrm.ir/article-1-632-en.pdf</fullTextUrl>
							  <doi_data>
								  <doi></doi>
								  <resource></resource>
							  </doi_data>
							  <citation_list>
							  </citation_list>
						  </journal_article>
					  </journal>
				  </cr_unixml:crossref>
			  </metadata>
			</record>
			
		</ListRecords>
		</OAI-PMH>
		 
  
  
  
  
 